These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 23254158)
1. Clinical evaluation of PET image reconstruction using a spatial resolution model. Andersen FL; Klausen TL; Loft A; Beyer T; Holm S Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158 [TBL] [Abstract][Full Text] [Related]
2. Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging. Aznar MC; Sersar R; Saabye J; Ladefoged CN; Andersen FL; Rasmussen JH; Löfgren J; Beyer T Eur J Radiol; 2014 Jul; 83(7):1177-1183. PubMed ID: 24780817 [TBL] [Abstract][Full Text] [Related]
3. Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors. Sheikhbahaei S; Marcus C; Wray R; Rahmim A; Lodge MA; Subramaniam RM Nucl Med Commun; 2016 Mar; 37(3):288-96. PubMed ID: 26650959 [TBL] [Abstract][Full Text] [Related]
4. Improvement in clinical evaluation of PET/CT images with high resolution algorithms. Orlandini LC; Betti M; Fulcheri C; Dona M; Fisicaro D; Castagnoli A Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):201-6. PubMed ID: 23486348 [TBL] [Abstract][Full Text] [Related]
5. The effect of reconstruction algorithms on semi-quantitative measurements in Özülker F; Babacan GB; Cengiz S; Özülker T Hell J Nucl Med; 2024; 27(2):85-92. PubMed ID: 39097805 [TBL] [Abstract][Full Text] [Related]
6. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols. Lartizien C; Kinahan PE; Comtat C J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270 [TBL] [Abstract][Full Text] [Related]
7. Impact of Point-Spread Function Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging. Aklan B; Oehmigen M; Beiderwellen K; Ruhlmann M; Paulus DH; Jakoby BW; Ritt P; Quick HH J Nucl Med; 2016 Jan; 57(1):78-84. PubMed ID: 26471697 [TBL] [Abstract][Full Text] [Related]
8. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845 [TBL] [Abstract][Full Text] [Related]
9. Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312 [TBL] [Abstract][Full Text] [Related]
10. Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods. Brendle C; Kupferschläger J; Nikolaou K; la Fougère C; Gatidis S; Pfannenberg C Eur J Radiol; 2015 Jan; 84(1):158-162. PubMed ID: 25467224 [TBL] [Abstract][Full Text] [Related]
11. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer. Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197 [TBL] [Abstract][Full Text] [Related]
12. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET. Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448 [TBL] [Abstract][Full Text] [Related]
13. Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET/CT. Lee YS; Kim JS; Kim KM; Kang JH; Lim SM; Kim HJ Ann Nucl Med; 2014 May; 28(4):340-8. PubMed ID: 24504938 [TBL] [Abstract][Full Text] [Related]
14. Evaluating image reconstruction methods for tumor detection in 3-dimensional whole-body PET oncology imaging. Lartizien C; Kinahan PE; Swensson R; Comtat C; Lin M; Villemagne V; Trébossen R J Nucl Med; 2003 Feb; 44(2):276-90. PubMed ID: 12571221 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of whole-body oncologic PET with time-of-flight and point-spread function for the hybrid PET/MR system. Shang K; Cui B; Ma J; Shuai D; Liang Z; Jansen F; Zhou Y; Lu J; Zhao G Eur J Radiol; 2017 Aug; 93():70-75. PubMed ID: 28668434 [TBL] [Abstract][Full Text] [Related]
17. Validation of fast-RAMLA in clinical PET. Sato H; Cho K; Fukushima Y; Shiiba M; Hakozaki K; Kiriyama T; Sakurai M; Kanaya K; Kumita S Ann Nucl Med; 2008 Dec; 22(10):869-76. PubMed ID: 19142705 [TBL] [Abstract][Full Text] [Related]
18. Impact of time of flight and point spread function on quantitative parameters of lung lesions in Huang K; Feng Y; Liang W; Li L BMC Med Imaging; 2021 Nov; 21(1):169. PubMed ID: 34773998 [TBL] [Abstract][Full Text] [Related]
19. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765 [TBL] [Abstract][Full Text] [Related]
20. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner. Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]